Glucagon Kit
NDC Package 51662-1498-1

11-digit billing NDC: 51662149801

Package Information

Glucagon kits is 1.1 Severe HypoglycemiaGlucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes.1.2 Diagnostic AidGlucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. This formulation utilizes a kit delivery system. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1498 and is authorized under FDA application NDA201849.

Identification & Billing

NDC Package Code
51662-1498-1
Package Description
1 KIT in 1 KIT * 1 mL in 1 VIAL, SINGLE-DOSE * 1 mL in 1 SYRINGE, GLASS
Product Code
11-Digit Billing Format
51662149801
RxNorm Crosswalk
RxCUI: 310497 - glucagon (rDNA) 1 MG Injection

Clinical Specifications

Proprietary Name
Glucagon
Non-Proprietary Name
Glucagon
Dosage Form
Kit - A packaged collection of related material.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Usage Information
1.1 Severe HypoglycemiaGlucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes.1.2 Diagnostic AidGlucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
Product Type
Human Prescription Drug
FDA Application #
NDA201849
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-10-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1498-1 identifies a specific commercial package of 1 kit in 1 kit * 1 ml in 1 vial, single-dose * 1 ml in 1 syringe, glass of Glucagon, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. This kit is formulated for intramuscular; intravenous use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on March 10, 2020. The current certification is valid through December 31, 2026.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662149801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1498-1
11-Digit CMS (5-4-2)
51662-1498-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.